Lancemaside A from Codonopsis lanceolata prevents hypertension by inhibiting NADPH oxidase 2-mediated MAPK signalling and improving NO bioavailability in rats.
You Kyoung ShinA Young HanYu Shan HsiehSoonho KwonJinhye KimKwang-Won LeeGeun Hee SeolPublished in: The Journal of pharmacy and pharmacology (2019)
Lancemaside A prevents hypertension in rats by inhibiting the activation of MAPK signalling and the impairment in nitric oxide bioavailability due to NOX2-mediated oxidative stress. Thus, LMA may act as a preventive agent for hypertension.